Scribe Therapeutics to Participate in Upcoming Conferences

Scribe Therapeutics Inc. (Scribe), a genetic medicines company unlocking the potential of CRISPR to transform human health, today announced that the Company will participate in the following conferences in September and October:

• Cantor Global Healthcare Conference: Members of management will be participating in the event on Thursday, September 19, 2024 in New York, NY. They will also be available for one-on-one meetings.
  

• BofA Healthcare Trailblazers Private Company Conference: Members of management will be participating and available for one-on-one meetings on Wednesday, September 25, 2024 in Boston, MA.

• Cell & Gene Meeting on the Mesa: Benjamin Oakes, Ph.D., Chief Executive Officer of Scribe, will present a corporate overview on Wednesday, October 9, 2024 at 10:30 a.m. MST in FLW Ballroom F of the Arizona Biltmore Hotel in Phoenix, AZ. Svetlana Lucas, Ph.D., Chief Business Officer, and David Parrot, Chief Financial Officer, will also be available for one-on-one meetings.